Učitavanje...
The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
The Women’s Health Initiative (WHI), a landmark randomized trial of menopausal hormone therapy (HT) for prevention of chronic disease in postmenopausal women aged 50–79, established that such therapy neither prevents coronary heart disease (CHD) nor yields a favorable balance of benefits and risks i...
Spremljeno u:
| Izdano u: | Metabolism |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4834454/ https://ncbi.nlm.nih.gov/pubmed/27085786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metabol.2016.01.004 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|